COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,785 Articles (22,523 medRxiv, 8,262 bioRxiv)

Most recent first Previous |  Page 2014: Articles 20131-20140  | Next

Trimeric SARS-CoV-2 Spike proteins produced from CHO-cells in bioreactors are high-quality antigens
Pino, P., Kint, J., Kiseljak, D., Agnolon, V., Corradin, G., KAJAVA, A. V., Rovero, P., Dijkman, R., Hartog, G. d., McLellan, J. S., Byrne, P., Wurm, M. J., Wurm, F. M.
10.1101/2020.11.15.382044 — Posted: 2020-11-16
Gene Expression Meta-Analysis Identifies Molecular Changes Associated with SARS-CoV Infection in Lungs
Park, A., Harris, L.
10.1101/2020.11.14.382697 — Posted: 2020-11-16
Examining the Persistence of Human Coronaviruses on Fresh Produce
Blondin-Brosseau, M., Harlow, J., Doctor, T., Nasheri, N.
10.1101/2020.11.16.385468 — Posted: 2020-11-16 Discussion: Onsite | Offsite
SARS-CoV-2-specific T cell memory is long-lasting in the majority of convalsecent COVID-19 individuals
Li, Z., Liu, J., Deng, H., Yang, X., Wang, H., Feng, X., Zelinskyy, G., Trilling, M., Sutter, K., Lu, M., Wang, B., Yang, D., Zheng, X., Liu, J.
10.1101/2020.11.15.383463 — Posted: 2020-11-16 Discussion: Onsite
Effects of inactivation method on SARS-CoV-2 virion proteins and structure
Loveday, E. K., Hain, K. S., Kochetkova, I., Hedges, J. F., Robison, A., Snyder, D. T., Brumfield, S. K., Young, M. J., Jutila, M. A., Chang, C. B., Taylor, M. P.
10.1101/2020.11.14.383026 — Posted: 2020-11-16
High resolution profiling of pathways of escape for SARS-CoV-2 spike-binding antibodies
Garrett, M. E., Galloway, J., Chu, H. Y., Itell, H. L., Stoddard, C. I., Wolf, C. R., Logue, J. K., McDonald, D., Matsen, F. A., Overbaugh, J.
10.1101/2020.11.16.385278 — Posted: 2020-11-16
Immunological memory to SARS-CoV-2 assessed for greater than six months after infection
Dan, J. M., Mateus, J., Kato, Y., Hastie, K. M., Faliti, C., Ramirez, S. I., Frazier, A., Yu, E. D., Grifoni, A., Rawlings, S. A., Peters, B., Krammer, F., Simon, V., Saphire, E. O., Smith, D., Weiskopf, D., Sette, A., Crotty, S.
10.1101/2020.11.15.383323 — Posted: 2020-11-16 Discussion: Onsite | Offsite
Novel gene-specific translation mechanism of dysregulated, chronic inflammation reveals promising, multifaceted COVID-19 therapeutics
Wang, L., Muneer, A., Xie, L., Zhang, F., Wu, B., Mei, L., Lenarcic, E. M., Feng, E. H., Song, J., Xiong, Y., Yu, X., Wang, C., Gheorghe, C., Torralba, K., Cook, J. G., Wan, Y. Y., Moorman, N. J., Song, H., Jin, J., Chen, X.
10.1101/2020.11.14.382416 — Posted: 2020-11-16
Discovery of rhodomyrtone as a broad-spectrum antiviral inhibitor with anti-SARS-CoV-2 activity
Tang, W., Lu, J., Song, Q.-Y., Li, M.-M., Chen, L.-F., Hu, L.-J., Yang, S.-M., Zhang, D.-M., Wang, Y., Li, Y.-L., Ye, W.-C.
10.1101/2020.11.14.382770 — Posted: 2020-11-16
COVATOR: A Software for Chimeric Coronavirus Identification
Habib, P.
10.1101/2020.11.14.383075 — Posted: 2020-11-16

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).